A cancer drug that targets the immune system may help improve the outlook for older adults with multiple myeloma , though a stem cell transplant remains the standard of care for relatively younger patients. Those are some of the findings from two studies in the Sept.
http://ift.tt/1pRzWGl
http://ift.tt/1pRzWGl
No comments:
Post a Comment